FDA Adverse Event Malfunction Summary report: N

ACCU-CHEK ® AVIVA TEST STRIPS

MDR report key: 1801837 · Received August 16, 2010

Report

Report Number
1823260-2010-04863
Event Type
Malfunction
Date Received
August 16, 2010
Date of Event
August 11, 2010
Report Date
August 30, 2010
Manufacturer
ROCHE DIAGNOSTICS
Product Code
LFR
PMA / PMN Number
K043474
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA.

Description of Event or Problem · 1

THE CUSTOMER ALLEGED A SIGNIFICANT BILIRUBIN INTERFERENCE WITH THE (B)(4) ACETAMINOPHEN APPLICATION. THE CUSTOMER RECEIVED A QUESTIONABLE RESULT FOR ACETAMINOPHEN ON THE ANALYTICAL P MODULE FOR ONE PATIENT SAMPLE COLLECTED FROM A TRANSPLANT PATIENT. THE DATE OF OCCURRENCE WAS NOT PROVIDED. THE INITIAL RESULT FOR ACETAMINOPHEN WAS 130 UMOL/L. THIS RESULT WAS REPORTED OUTSIDE THE LABORATORY. THE BILIRUBIN CONCENTRATION FOR THIS SAMPLE WAS ABOUT 300 UMOL/L. A URINE SAMPLE OBTAINED FROM THE PATIENT WAS TESTED BY (B)(6) AND NO ACETAMINOPHEN WAS DETECTED IN THIS URINE SAMPLE. THE PATIENT WAS TREATED WITH (NAC) N-ACETYL CYSTEINE DUE TO THE QUESTIONABLE ACETAMINOPHEN RESULT OF 130 UMOL/L. NO ADVERSE EVENT HAS BEEN ALLEGED REAGARDING THIS EVENT. THE ACETAMINOPHEN REAGENT LOT NUMBER WAS NOT PROVIDED.

Description of Event or Problem · 1

CALLER REPORTED BLOOD GLUCOSE RESULTS OF 281 MG/DL AT 5:05PM, 217 MG/DL A HALF MINUTE LATER, 110 MG/DL A FEW SECONDS LATER, AND 135 MG/DL A FEW SECONDS LATER ON THE ACCU-CHEK SYSTEM. REPORTED NO ADVERSE EVENT RELATIVE TO DISCREPANCY. A REQUEST WAS MADE FOR THE RETURN OF THE METER AND STRIPS, REPLACEMENT SENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACCU-CHEK ® AVIVA TEST STRIPS BLOOD GLUCOSE MONITORING TEST STRIPS LFR ROCHE DIAGNOSTICS NA 301983

Patients

Seq Age Sex Outcome Treatment
1 060 YR LEVEMIR| NOVOLOG